These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22531980)

  • 1. Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice.
    Tsuchiya H; Ikeda Y; Ebata Y; Kojima C; Katsuma R; Tsuruyama T; Sakabe T; Shomori K; Komeda N; Oshiro S; Okamoto H; Takubo K; Hama S; Shudo K; Kogure K; Shiota G
    Hepatology; 2012 Oct; 56(4):1319-30. PubMed ID: 22531980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinoids as promising treatment for non-alcoholic fatty liver disease].
    Tsuchiya H
    Yakugaku Zasshi; 2012; 132(8):903-9. PubMed ID: 22864348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor.
    Yoshino S; Satoh T; Yamada M; Hashimoto K; Tomaru T; Katano-Toki A; Kakizaki S; Okada S; Shimizu H; Ozawa A; Tuchiya T; Ikota H; Nakazato Y; Mori M; Matozaki T; Sasaki T; Kitamura T; Mori M
    Endocrinology; 2014 Sep; 155(9):3459-72. PubMed ID: 25004093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of puerarin on expressions of leptin receptor mRNA, phosphorylated Janus kinase 2/phosphorylated signal transducers and activators of transcription 3 proteins in the liver of rats with non-alcoholic fatty liver].
    Zheng PY; Ma ZS; Hua YQ; Liu T; Xing LJ; Ji G
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):921-7. PubMed ID: 18782535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice.
    Shimizu M; Sakai H; Shirakami Y; Iwasa J; Yasuda Y; Kubota M; Takai K; Tsurumi H; Tanaka T; Moriwaki H
    Cancer Prev Res (Phila); 2011 Jan; 4(1):128-36. PubMed ID: 21071580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
    Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A
    Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant.
    Chen HJ; Liu J
    Biomed Pharmacother; 2018 Jan; 97():1386-1396. PubMed ID: 29156528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
    Imajo K; Fujita K; Yoneda M; Nozaki Y; Ogawa Y; Shinohara Y; Kato S; Mawatari H; Shibata W; Kitani H; Ikejima K; Kirikoshi H; Nakajima N; Saito S; Maeyama S; Watanabe S; Wada K; Nakajima A
    Cell Metab; 2012 Jul; 16(1):44-54. PubMed ID: 22768838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.
    Ge F; Zhou S; Hu C; Lobdell H; Berk PD
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G855-66. PubMed ID: 20595619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
    Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
    Yang YY; Tsai TH; Huang YT; Lee TY; Chan CC; Lee KC; Lin HC
    Hepatology; 2012 May; 55(5):1540-50. PubMed ID: 22183953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adipocytokines in hepatic fibrogenesis.
    Ikejima K; Okumura K; Kon K; Takei Y; Sato N
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S87-92. PubMed ID: 17567476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
    Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.